Fink, David S.
Schleimer, Julia P.
Keyes, Katherine M.
Branas, Charles C.
Cerdá, Magdalena
Gruenwald, Paul
Hasin, Deborah
Funding for this research was provided by:
National Institute on Drug Abuse (K99DA055724)
National Institute on Drug Abuse (T32DA031099)
New York State Psychiatric Institute
Article History
Received: 10 July 2023
Accepted: 11 January 2024
First Online: 14 February 2024
Declarations
:
: Dr Hasin reported support from Syneos Health for an unrelated project. Dr Keyes reported personal fees from National Prescription Opioid Litigation related to expert witness work outside the submitted work. No other disclosures were reported.
: Not applicable (This study is a systematic review and does not contain clinical studies or patient data).